XML 56 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Lease Obligation
12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Lease Obligation

14. LEASE OBLIGATION

In December 2018, the Company entered into an operating lease with Vertex Pharmaceuticals Inc. (“Vertex”) to lease approximately 13,170 square feet of office, laboratory and vivarium space at 50 Northern Ave, Boston, Massachusetts, expiring in December 2020. In July 2020, the Company extended the term of the lease through February 2021.

On July 21, 2020, the Company entered into an operating lease agreement for 20,752 square feet of office, lab and animal care facility space located in Boston, Massachusetts for the Company’s corporate headquarters. The commencement date of the lease was February 19, 2021 and the lease term is 63 months. The lease provides a three-month free rent period, which commenced on the lease commencement date. The base rent at commencement is $145 thousand per month and escalates by 3% annually for total lease payments during the term of $9.3 million.

The Company's lease agreement requires the Company to maintain a cash letter of credit to secure their obligations under the lease of $0.9 million. This balance is included in other assets on the accompanying consolidated balance sheets. The Company recognized a right of use asset of $7.5 million and an operating lease liability of $7.5 million upon the commencement of the lease.

 

The components of the lease costs which are included in the consolidated statements of operations and comprehensive loss were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Operating lease costs

 

$

1,693

 

 

$

1,011

 

Variable lease costs

 

 

479

 

 

 

706

 

Total lease costs

 

$

2,172

 

 

$

1,717

 

 

Our variable lease cost primarily related to operating expenses, parking, taxes and insurance associated with our operating leases.

 

Supplemental cash flow information relating to the Company’s leases were as follows (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of
   lease liabilities (operating cash flows)

 

$

1,259

 

 

$

1,025

 

 

The remaining lease terms and discount rates related to our leases were as follows:

 

 

 

As of December 31,

 

 

2021

 

2020

Remaining lease term

 

4.4 years

 

0.2 years

Discount Rate

 

7.7%

 

8.0%

 

The future minimum lease payments for the Company’s operating lease as of December 31, 2021, were as follows (in thousands):

 

Fiscal Year

 

Operating
Leases

 

2022

 

$

1,774

 

2023

 

 

1,827

 

2024

 

 

1,882

 

2025

 

 

1,938

 

2026

 

 

817

 

Thereafter

 

 

 

Total minimum lease payments

 

 

8,238

 

Less amounts representing interest or imputed interest

 

 

1,251

 

Present value of lease liabilities

 

$

6,987